Top Markets
Coin of the day
Abnova (Taiwan) Corporation Abnova (Taiwan) Corporation

Abnova (Taiwan) Corporation

4133
株式のランク #26487
Abnova (Taiwan) Corporation specializes in the development and distribution of... Abnova (Taiwan) Corporation specializes in the development and distribution of a comprehensive range of recombinant proteins and antibodies. The company's extensive product portfolio caters to diverse research and diagnostic applications, featuring specialized reagents for SARS-CoV/CoV-2, nucleic acids (both DNA and RNA), and various proteins and peptides. Their offerings further include items like DNAxPab, laboratory beads, dyes, cellular lysates, microscopic slides, antibody pairs and associated kits, as well as antibody and tissue arrays. Additionally, they provide in situ hybridization products, advanced laboratory systems and automation, GMP-grade and analyte-specific reagents, and solutions for in vitro diagnostics. Beyond these product lines, Abnova supplies a broad spectrum of antibody types, such as MaxPab, monoclonal, polyclonal, recombinant, conjugate, secondary/tag, IHC/pathology, and those specifically targeting circulating rare cells. The company also delivers integrated solutions and services, encompassing gene synthesis and cytogenetic analysis, peptide services, protein expression and conjugations, custom antibody generation, and assay development. Abnova (Taiwan) Corporation operates from its headquarters in Taipei, Taiwan.
株価
$0.66300973
時価総額
$40.15M
変化(1日)
1.46%
変化(1年)
-20.61%
TW
取引 Abnova (Taiwan) Corporation (4133)

カテゴリー

Abnova (Taiwan) Corporation(4133)の配当利回りの履歴
Abnova (Taiwan) Corporation(銘柄コード: 4133)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Abnova (Taiwan) Corporation(4133)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)